Fact CheckerSign in

NCT07088874Recruiting

Novel Biomarkers and Postoperative Kidney Injury in Radical Nephrectomy

Novel Biomarkers to Predict Acute Kidney Injury and Chronic Kidney Disease After Radical Nephrectomy: an Exploratory Prospective Cohort Study

Source: ClinicalTrials.gov · Last updated 8 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The incidence of acute kidney injury (AKI) after radical nephrectomy exceeds 40%. Currently, the KDIGO criteria are the recognized diagnostic standard for AKI. These criteria primarily use serum creatinine and urine output as key indicators, but both parameters have certain limitations, such as delayed response, insensitivity, and inaccuracy. This study aims to simultaneously monitor perioperative novel renal damaging, stressful, and functional biomarkers in patients undergoing radical nephrectomy, and to investigate their predictive value for AKI and postoperative 1-year chronic kidney disease (CKD).

Status (registry)
Recruiting
Study type
Observational
Enrollment
60 (estimated)
First submitted
10 Jul 2025
Start date
2 Aug 2025
Primary completion date
30 Jul 2026
Lead sponsor
Peking University First Hospital
NCT number
NCT07088874

What you commit to

  • Study type: Observational
  • Planned participants: 60
  • From 2 Aug 2025 to the primary completion date, 30 Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Other conditions deemed by the investigator as unsuitable for participation in this study.

Lab values

  • Preoperative diagnosis of chronic kidney disease stages G4 or G5 (GFR \<30 mL/min/1.73m²);

Other

  • Solitary kidney;
  • Tumor invasion of the vena cava requiring thrombectomy;

Who the study is looking for

  • Age ≥18 years;
  • Scheduled to undergo unilateral radical nephrectomy.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Department of Anesthesiology and Critical Care Medicine, Peking University First Hospital
Coordinator of this site? Confirm its status
BeijingChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.